387 related articles for article (PubMed ID: 29349710)
1. Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement.
Koopman T; Buikema HJ; Hollema H; de Bock GH; van der Vegt B
Breast Cancer Res Treat; 2018 May; 169(1):33-42. PubMed ID: 29349710
[TBL] [Abstract][Full Text] [Related]
2. Proliferation assessment in breast carcinomas using digital image analysis based on virtual Ki67/cytokeratin double staining.
Røge R; Riber-Hansen R; Nielsen S; Vyberg M
Breast Cancer Res Treat; 2016 Jul; 158(1):11-19. PubMed ID: 27283833
[TBL] [Abstract][Full Text] [Related]
3. A Comparison of Visual Assessment and Automated Digital Image Analysis of Ki67 Labeling Index in Breast Cancer.
Zhong F; Bi R; Yu B; Yang F; Yang W; Shui R
PLoS One; 2016; 11(2):e0150505. PubMed ID: 26928407
[TBL] [Abstract][Full Text] [Related]
4. Sequential immunohistochemistry and virtual image reconstruction using a single slide for quantitative KI67 measurement in breast cancer.
Serna G; Simonetti S; Fasani R; Pagliuca F; Guardia X; Gallego P; Jimenez J; Peg V; Saura C; Eppenberger-Castori S; Ramon Y Cajal S; Terracciano L; Nuciforo P
Breast; 2020 Oct; 53():102-110. PubMed ID: 32707454
[TBL] [Abstract][Full Text] [Related]
5. What is the added value of digital image analysis of HER2 immunohistochemistry in breast cancer in clinical practice? A study with multiple platforms.
Koopman T; Buikema HJ; Hollema H; de Bock GH; van der Vegt B
Histopathology; 2019 May; 74(6):917-924. PubMed ID: 30585668
[TBL] [Abstract][Full Text] [Related]
6. A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue.
Laurinavicius A; Plancoulaine B; Laurinaviciene A; Herlin P; Meskauskas R; Baltrusaityte I; Besusparis J; Dasevicius D; Elie N; Iqbal Y; Bor C
Breast Cancer Res; 2014; 16(2):R35. PubMed ID: 24708745
[TBL] [Abstract][Full Text] [Related]
7. Validity and reliability of Ki-67 assessment in oestrogen receptor positive breast cancer.
Jing N; Fang C; Williams DS
Pathology; 2017 Jun; 49(4):371-378. PubMed ID: 28450087
[TBL] [Abstract][Full Text] [Related]
8. Impact of Primary Antibody Clone, Format, and Stainer Platform on Ki67 Proliferation Indices in Breast Carcinomas.
Røge R; Nielsen S; Riber-Hansen R; Vyberg M
Appl Immunohistochem Mol Morphol; 2019; 27(10):732-739. PubMed ID: 31460869
[TBL] [Abstract][Full Text] [Related]
9. Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study.
Acs B; Pelekanou V; Bai Y; Martinez-Morilla S; Toki M; Leung SCY; Nielsen TO; Rimm DL
Lab Invest; 2019 Jan; 99(1):107-117. PubMed ID: 30181553
[TBL] [Abstract][Full Text] [Related]
10. Prognostic potential of automated Ki67 evaluation in breast cancer: different hot spot definitions versus true global score.
Robertson S; Acs B; Lippert M; Hartman J
Breast Cancer Res Treat; 2020 Aug; 183(1):161-175. PubMed ID: 32572716
[TBL] [Abstract][Full Text] [Related]
11. Practical issues concerning the implementation of Ki-67 proliferative index measurement in breast cancer reporting.
Harvey J; Thomas C; Wood B; Hardie M; Dessauvagie B; Combrinck M; Frost FA; Sterrett G
Pathology; 2015 Jan; 47(1):13-20. PubMed ID: 25474507
[TBL] [Abstract][Full Text] [Related]
12. Reliability of Ki67 visual scoring app compared to eyeball estimate and digital image analysis and its prognostic significance in hormone receptor-positive breast cancer.
Arun I; Venkatesh S; Ahmed R; Agrawal SK; Leung SCY
APMIS; 2021 Aug; 129(8):489-502. PubMed ID: 34053140
[TBL] [Abstract][Full Text] [Related]
13. Bimodality of intratumor Ki67 expression is an independent prognostic factor of overall survival in patients with invasive breast carcinoma.
Laurinavicius A; Plancoulaine B; Rasmusson A; Besusparis J; Augulis R; Meskauskas R; Herlin P; Laurinaviciene A; Abdelhadi Muftah AA; Miligy I; Aleskandarany M; Rakha EA; Green AR; Ellis IO
Virchows Arch; 2016 Apr; 468(4):493-502. PubMed ID: 26818835
[TBL] [Abstract][Full Text] [Related]
14. Reproducibility and Prognostic Potential of Ki-67 Proliferation Index when Comparing Digital-Image Analysis with Standard Semi-Quantitative Evaluation in Breast Cancer.
Ács B; Madaras L; Kovács KA; Micsik T; Tőkés AM; Győrffy B; Kulka J; Szász AM
Pathol Oncol Res; 2018 Jan; 24(1):115-127. PubMed ID: 28401450
[TBL] [Abstract][Full Text] [Related]
15. Digital immunohistochemistry wizard: image analysis-assisted stereology tool to produce reference data set for calibration and quality control.
Plancoulaine B; Laurinaviciene A; Meskauskas R; Baltrusaityte I; Besusparis J; Herlin P; Laurinavicius A
Diagn Pathol; 2014; 9 Suppl 1(Suppl 1):S8. PubMed ID: 25565221
[TBL] [Abstract][Full Text] [Related]
16. Potential Pitfalls in Diagnostic Digital Image Analysis: Experience with Ki-67 and PHH3 in Gastrointestinal Neuroendocrine Tumors.
Hacking SM; Sajjan S; Lee L; Ziemba Y; Angert M; Yang Y; Jin C; Chavarria H; Kataria N; Jain S; Nasim M
Pathol Res Pract; 2020 Mar; 216(3):152753. PubMed ID: 31761497
[TBL] [Abstract][Full Text] [Related]
17. Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods.
Tang LH; Gonen M; Hedvat C; Modlin IM; Klimstra DS
Am J Surg Pathol; 2012 Dec; 36(12):1761-70. PubMed ID: 23026928
[TBL] [Abstract][Full Text] [Related]
18. Comparison between digital image analysis and visual assessment of immunohistochemical HER2 expression in breast cancer.
Jakobsen MR; Teerapakpinyo C; Shuangshoti S; Keelawat S
Pathol Res Pract; 2018 Dec; 214(12):2087-2092. PubMed ID: 30377025
[TBL] [Abstract][Full Text] [Related]
19. Invasive lobular carcinoma of the breast: assessment of proliferative activity using automated Ki-67 immunostaining.
Dessauvagie B; Thomas A; Thomas C; Robinson C; Combrink M; Budhavaram V; Kunjuraman B; Meehan K; Sterrett G; Harvey J
Pathology; 2019 Dec; 51(7):681-687. PubMed ID: 31630876
[TBL] [Abstract][Full Text] [Related]
20. Standardized Ki67 Diagnostics Using Automated Scoring--Clinical Validation in the GeparTrio Breast Cancer Study.
Klauschen F; Wienert S; Schmitt WD; Loibl S; Gerber B; Blohmer JU; Huober J; Rüdiger T; Erbstößer E; Mehta K; Lederer B; Dietel M; Denkert C; von Minckwitz G
Clin Cancer Res; 2015 Aug; 21(16):3651-7. PubMed ID: 25501130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]